Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

European Journal of Clinical Investigation

Volumn 30, Issue 11, 2000, Pages 980-987

  Tonolo, G ^a,b,c   Melis, M G ^a,b   Formato, M ^a,b   Angius, M F ^a,b   Carboni, A ^a,b   Brizzi, P ^a,b   Ciccarese, M ^a,b   Cherchi, G M ^a,b   Maioli, M ^a,b  

^a Institute of Clinica Medica   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Istituto di Clinica Medica   (Italy)

Author keywords

Glycosaminoglycans; Metabolic syndrome; Microalbuminuria; NIDDM

Indexed keywords

ALBUMIN; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

ALBUMINURIA; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS; BLOOD PRESSURE; CHOLESTEROL, LDL; CHOLESTYRAMINE; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRATES; NITRITES; SIMVASTATIN;

EID: 0033673164     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00735.x     Document Type: Article

References (47)

1. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
2. Randomized trial of cholesterol lowering in 4444 patients coronary heart disease: The Scandanavian Survival Study (4s)
3. Can the clinical efficacy of the HMG CoA reductase inhibitors be explained solely by their effects on LDL-Cholesterol?
4. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
5. The effects of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasodilatation
6. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
7. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: Role of scavenger receptor and endothelium-derived nitric oxide
8. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: Clinical and pharmacological implications in atherosclerosis
9. Simvastatin inhibits PDGF induced DNA synthesis in human glomerular mesangial cells
10. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes mellitus
11. Risk factors for death in treated hypertensive patients
12. Reduction of albumin excretion rate in normotensive non-insulin-dependent microalbuminuric diabetic patients during long term Simvastatin treatment
13. Direct vascular effects of HMG-CoA reductase inhibitors
14. Maioli Cyclical variation of plasma lipids, apolipoproteins and lipoprotein (a) during menstrual cycle in normal women
15. Urinary excretion of acid glycosaminoglycans in the aged
16. Low suphated chondroitin sulphate in human blood and urine
17. Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects and their effects on lipoprotein lipase
18. Serum lipids and apolipoprotein A1, A2 and B in hypertyroidism before and after treatment
19. Estimate of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
20. Urinary infection and albumin excretion in insulin dependent diabetes mellitus: Implications for the measurement of microalbuminuria
21. Modified uronic acid carbazole reaction
22. A new electrophoretic method for the complete separation of all non-animal glycosaminoglycans in a monodimensional run
23. Modifications of low density lipoproteins induced by the interaction with human plasma glycosaminoglycan-protein complexes
24. Analysis of nitrate, nitrite and 15N nitrate in biological fluids
25. Restoration of endothelium-dependent relaxation by dietapy treatment of atherosclerosis
26. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans
27. High circulating LDLs play a role in the maintenance of high blood pressure in essential hypertensive patients
28. Pravastatin reduces cardiovascular reactivity to noradrenaline and angiotensin II in hypercholesterolemic hypertensives
29. Partial remission of nephrotic syndrome in patients on long-term simvastatin
30. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy
31. Renal function and insulin sensitivity during simvastatin treatment in Type 2 (non insulin dependent diabetic patients with microalbuminuria
32. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy
33. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients
34. The progression of renal disease
35. Urinary glycosaminoglycan excretion in NIDDM subjects, its relationship to albuminuria
36. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate poteoglycan and laminin
37. Trans-capillary escape rate of albumin in type II diabetic patients. The relation with microalbuminuria and hypertension
38. Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice
39. Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome
40. Albuminuria is an independent predictor of carotid intima-media thickness and atherosclerosis in NIDDM patients
41. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent diabetes mellitus
42. Impaired endothelium-dependent vasodilatation in patients with insulin dependent diabetes mellitus
43. Vitamin C improves endothelium-dependent vasodilatation in patients with non-insulin-dependent diabetes mellitus
44. Nitric oxide availability in diabetes mellitus
45. Beyond lipids- the role of the endothelium in coronary artery disease
46. Nitrite plasma levels in normolipemic and hypercholesterolemic arteriopathics after vasoactive and lipid-lowering treatment
47. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia